Scientific-Sessions | World’s Leading Cancer Conference | Oncology Conferences | Radiology Meetings

Scientific Sessions

Scientific Session Day 1
Scientific Session Day 2
Scientific Session Day 3

Session 1Specific Cancer Types

Radiology and Imaging are integral to the diagnosis, staging, and management of various cancer types. For instance, mammography is essential in the early detection of breast cancer, often identifying tumors before they are palpable. Lung cancer screening with low-dose CT scans has proven effective in reducing mortality among high-risk populations by detecting cancers at an earlier, more treatable stage. In prostate cancer, MRI is increasingly used for precise localization of tumors, guiding biopsies, and planning surgeries or radiation therapy. Similarly, PET scans are invaluable in assessing the metabolic activity of cancers such as lymphoma, allowing for accurate staging and monitoring of treatment response. These imaging modalities not only enhance the accuracy of diagnoses but also facilitate targeted therapies, leading to improved outcomes. As imaging technology advances, its role in personalized cancer care becomes ever more prominent, enabling tailored treatment strategies based on the specific characteristics of an individual’s cancer.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 2Radiology and Imaging

Radiology and Imaging play a crucial role in modern medicine, offering non-invasive methods for diagnosing and treating a variety of conditions. This field encompasses several techniques, including X-rays, CT scans, MRI, and ultrasound, each providing unique insights into the human body’s internal structures. Radiologists are medical doctors specialized in interpreting these images to detect abnormalities such as fractures, tumors, and infections. Advances in imaging technology, such as high-resolution and functional imaging, have significantly enhanced diagnostic accuracy and treatment planning. Furthermore, interventional radiology enables minimally invasive procedures guided by imaging, reducing the need for traditional surgery and promoting faster recovery times for patients. As technology continues to evolve, the potential for more precise and personalized medical care through radiology and imaging grows, underscoring its vital contribution to healthcare.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 3Precision Oncology

Precision oncology is an innovative approach to cancer treatment that focuses on tailoring therapies based on the individual genetic, environmental, and lifestyle factors unique to each patient. Unlike traditional treatments that apply a uniform strategy to all patients, precision oncology aims to specifically target the molecular and genetic characteristics of a patient’s tumor. This approach often involves genomic profiling to identify mutations or other molecular features of the cancer, which then guides the selection of targeted therapies. These therapies are designed to attack the cancer’s specific drivers, potentially increasing the effectiveness of treatment while minimizing side effects. Precision oncology represents a shift towards more personalized and effective cancer care, leveraging advances in genomics and molecular biology to improve patient outcomes.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 4Cancer Prevention and Early Detection

Cancer prevention and early detection are pivotal components in the fight against cancer, aiming to reduce the incidence and mortality associated with this diverse group of diseases. Preventative strategies include lifestyle modifications such as adopting a healthy diet, engaging in regular physical activity, avoiding tobacco, and limiting alcohol consumption, all of which are known to decrease the risk of developing cancer. Additionally, vaccination programs, such as those for human papillomavirus (HPV) and hepatitis B virus (HBV), play a crucial role in preventing cancers caused by these infections. Early detection through screening programs significantly improves outcomes by identifying cancers at an earlier, more treatable stage. Mammograms for breast cancer, Pap smears for cervical cancer, colonoscopies for colorectal cancer, and low-dose CT scans for lung cancer in high-risk populations are some of the effective screening methods currently in practice. Advances in imaging technologies and biomarker research continue to enhance the sensitivity and specificity of these screening tools, enabling earlier and more accurate detection. Public health initiatives focusing on education and awareness further support these efforts, underscoring the importance of regular screenings and preventative measures in reducing the global cancer burden.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 5Artificial Intelligence in Radiology

Artificial Intelligence (AI) is revolutionizing the field of radiology, offering innovative solutions to enhance diagnostic accuracy, streamline workflow, and improve patient care. AI algorithms, trained on vast datasets of medical images, can analyze images with remarkable speed and precision, assisting radiologists in detecting abnormalities and making diagnoses. For instance, AI-powered image analysis tools can help identify suspicious lesions in mammograms or detect subtle signs of disease in CT scans and MRIs, augmenting the radiologist’s expertise and reducing the likelihood of missed findings. Moreover, AI algorithms can aid in triaging imaging studies, prioritizing cases based on urgency and clinical relevance, thereby optimizing radiologists’ workflow and improving patient outcomes. Additionally, AI holds promise in predictive analytics, utilizing patient data to forecast disease progression and treatment response, guiding personalized treatment plans. As AI continues to evolve, its integration into radiology practice promises to revolutionize patient care by providing more accurate, efficient, and accessible diagnostic services. However, challenges such as data privacy, algorithm transparency, and regulatory oversight must be addressed to ensure the responsible and ethical deployment of AI in radiology. Overall, AI represents a transformative force in radiology, empowering healthcare professionals to deliver higher-quality care and ultimately improve patient outcomes.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 6Breast Cancer: New Horizons

Breast cancer research is continuously advancing, offering new horizons in detection, treatment, and survivorship. Innovations in imaging technology, such as 3D mammography (tomosynthesis), offer improved accuracy in detecting breast abnormalities, particularly in women with dense breast tissue. Molecular profiling and genetic testing have enabled personalized treatment approaches, allowing clinicians to tailor therapies based on the specific characteristics of a patient’s tumor. Targeted therapies, including monoclonal antibodies and PARP inhibitors, are showing promise in treating certain subtypes of breast cancer, while immunotherapy holds potential for stimulating the body’s immune system to fight cancer cells. Advances in surgical techniques, such as oncoplastic surgery and nipple-sparing mastectomy, aim to preserve aesthetics and improve quality of life for breast cancer survivors. Additionally, supportive care strategies, including survivorship programs and psychosocial interventions, address the holistic needs of patients throughout their cancer journey. Collaborative efforts among researchers, clinicians, and advocates continue to drive progress in breast cancer research, offering hope for improved outcomes and ultimately a cure for this complex disease.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 7Chemotherapy: Current Trends and Future Directions

Chemotherapy continues to evolve, with current trends emphasizing targeted therapies and personalized treatment approaches. Precision medicine techniques, such as molecular profiling and genetic testing, enable clinicians to identify specific molecular characteristics of tumors, guiding the selection of chemotherapy drugs tailored to individual patients. Combination therapies, utilizing multiple drugs with complementary mechanisms of action, are increasingly utilized to enhance treatment efficacy while minimizing side effects. Moreover, advancements in supportive care, including anti-nausea medications and growth factor support, aim to alleviate the adverse effects associated with chemotherapy. Looking ahead, emerging trends in chemotherapy research focus on novel drug delivery systems, such as nanoparticles and immunoliposomes, which enhance drug delivery to tumor cells while sparing healthy tissues. Additionally, immunotherapy combined with chemotherapy holds promise in harnessing the body’s immune system to target cancer cells more effectively. As research in chemotherapy continues to progress, the future of cancer treatment holds potential for more precise, targeted, and tolerable therapies, improving outcomes and quality of life for patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 8Tumor Biology and Microenvironment

Tumor biology and the surrounding microenvironment play critical roles in cancer development, progression, and response to treatment. Tumor cells interact dynamically with their microenvironment, which comprises various components such as blood vessels, immune cells, fibroblasts, and extracellular matrix. These interactions influence key processes including tumor growth, invasion, metastasis, and resistance to therapy. For instance, tumor cells can manipulate the microenvironment to promote angiogenesis, ensuring a blood supply for their growth, or evade immune surveillance by inhibiting immune cell function. Additionally, the extracellular matrix provides structural support to tumors and can act as a barrier to drug penetration, contributing to treatment resistance. Understanding the intricate crosstalk between tumor cells and the microenvironment is crucial for developing effective cancer therapies. Emerging research explores strategies to target components of the tumor microenvironment, such as anti-angiogenic therapies to disrupt blood vessel formation or immunotherapies to enhance immune cell-mediated tumor destruction. By unraveling the complexities of tumor biology and the microenvironment, researchers aim to identify novel therapeutic targets and improve treatment outcomes for cancer patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 9Radiogenomics: Bridging Radiology and Genomics in Cancer Research

Radiogenomics represents a burgeoning field at the intersection of radiology and genomics, aiming to elucidate the molecular underpinnings of imaging phenotypes in cancer research. By correlating radiological features captured through medical imaging with genomic data obtained from tumor samples, radiogenomics seeks to uncover associations between imaging characteristics and underlying molecular alterations. This approach holds immense potential for advancing cancer diagnosis, prognosis, and treatment response prediction. For instance, radiogenomic analyses may identify imaging biomarkers indicative of specific genetic mutations or molecular subtypes, enabling non-invasive characterization of tumors and guiding personalized treatment strategies. Furthermore, radiogenomic studies can provide insights into tumor biology and microenvironmental factors influencing imaging phenotypes, enhancing our understanding of cancer heterogeneity and therapeutic resistance mechanisms. As the field of radiogenomics continues to evolve, collaborative efforts between radiologists, oncologists, and genomic researchers are essential for translating radiogenomic findings into clinical applications, ultimately improving patient outcomes in cancer care.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 10Cancer Screening Programs

Cancer screening programs are vital public health initiatives aimed at detecting cancer at early, more treatable stages, ultimately reducing mortality rates. These programs typically target specific cancers with well-established screening methods, such as mammography for breast cancer, Pap smears for cervical cancer, colonoscopies for colorectal cancer, and low-dose CT scans for lung cancer in high-risk populations. The success of these programs relies on several factors, including widespread participation, access to screening services, quality assurance measures, and effective communication of screening guidelines to healthcare providers and the general public. Moreover, ongoing research and advancements in screening technologies, such as molecular and imaging-based tests, hold promise for improving the sensitivity, specificity, and convenience of cancer screening. Collaborative efforts among healthcare organizations, policymakers, advocacy groups, and community stakeholders are essential for developing and implementing comprehensive cancer screening programs that address the unique needs of diverse populations. By promoting early detection and timely intervention, cancer screening programs contribute significantly to reducing the burden of cancer and improving patient outcomes.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 11General Oncology

General oncology encompasses the comprehensive study and management of cancer across various aspects, including prevention, diagnosis, treatment, and supportive care. This multidisciplinary field involves collaboration among medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists, and other healthcare professionals to provide personalized and integrated care to cancer patients. Key areas of focus in general oncology include cancer epidemiology and risk factors, tumor biology and molecular profiling, cancer screening and early detection strategies, treatment modalities such as surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, as well as palliative and supportive care to improve patients’ quality of life. Additionally, ongoing research in general oncology encompasses clinical trials, translational research, and innovations in cancer therapeutics and diagnostics aimed at advancing our understanding of cancer biology and improving treatment outcomes. By addressing the multifaceted aspects of cancer care, general oncology plays a pivotal role in reducing the global burden of cancer and improving survival rates for cancer patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 12Childhood Cancer: Current Research and Future Prospects

Current research in childhood cancer focuses on targeted therapies based on genetic mutations, immunotherapy, and reducing treatment-related toxicity. Future prospects include personalized treatments, integrating genomic and immunologic approaches, and precision prevention initiatives. Collaboration among researchers, clinicians, and advocacy groups is crucial for advancing these goals and improving outcomes for pediatric cancer patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 13Epigenetics in Cancer

Epigenetics, a field exploring heritable changes in gene expression without alterations in DNA sequence, plays a crucial role in cancer. These changes, including DNA methylation, histone modifications, and non-coding RNA expression, contribute significantly to cancer initiation and progression. Aberrant epigenetic modifications can silence tumor suppressor genes or activate oncogenes, driving tumor growth and metastasis. Understanding these mechanisms has led to the development of epigenetic-based therapies targeting enzymes involved in epigenetic regulation, showing promise in preclinical and clinical studies across various cancer types. Additionally, advancements in sequencing technologies allow for a deeper understanding of the intricate epigenetic landscapes of cancer cells, paving the way for personalized treatment strategies tailored to individual epigenetic profiles. However, challenges such as off-target effects and acquired resistance necessitate ongoing research to fully harness the potential of epigenetics in cancer therapy.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 14Colorectal Cancer: From Screening to Treatment

Colorectal cancer (CRC) management encompasses a comprehensive approach from screening to treatment, aiming to reduce mortality rates and improve patient outcomes. Screening programs play a pivotal role in early detection, utilizing methods such as colonoscopy, fecal occult blood tests (FOBT), or stool DNA tests to identify CRC or its precursor lesions at a stage when treatment is most effective. Diagnostic imaging techniques, including CT scans and MRI, aid in accurately staging the disease, guiding treatment decisions and prognosis assessment. Treatment strategies for CRC vary based on factors such as disease stage, tumor location, and patient health status. Surgical resection remains the primary treatment for localized CRC, often supplemented by adjuvant chemotherapy or radiation therapy in advanced cases. Targeted therapies, such as monoclonal antibodies targeting VEGF or EGFR, have significantly improved outcomes for metastatic CRC patients. Additionally, immunotherapy, particularly immune checkpoint inhibitors, has shown promise in specific subsets of CRC patients with MSI-H or dMMR tumors. Precision medicine approaches, guided by genomic profiling, enable tailored therapies that target specific molecular alterations driving CRC progression. Supportive care interventions, including nutritional support and psychosocial assistance, are integral components of CRC treatment, enhancing patient well-being throughout their journey. Ongoing research continues to advance screening methods, diagnostic tools, and treatment options, with the aim of further improving outcomes and quality of life for CRC patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Session 15Cancer Biomarkers

Cancer biomarkers are measurable indicators found in blood, tissue, or other bodily fluids that provide information about the presence, development, or progression of cancer. These biomarkers can include proteins, genetic mutations, circulating tumor cells, microRNAs, or other molecules that are specific to cancer cells or indicative of the body’s response to cancer. Biomarkers play a crucial role in cancer diagnosis, prognosis, treatment selection, and monitoring of treatment response. For example, certain biomarkers can help identify individuals at high risk of developing cancer, detect cancer at early stages when treatment is most effective, predict a patient’s response to specific therapies, or monitor disease progression and recurrence. Advances in biomarker research have led to the development of companion diagnostic tests, which are used to identify patients who are most likely to benefit from targeted therapies or immunotherapies. Additionally, biomarker discovery efforts continue to uncover new molecular signatures and biological pathways associated with cancer, offering potential targets for the development of novel therapies. Overall, cancer biomarkers play a critical role in personalized medicine approaches, facilitating more precise and effective cancer diagnosis and treatment strategies tailored to the individual patient.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 16Emerging Trends in Cancer Treatment

Emerging trends in cancer treatment are shaping the landscape of oncology, offering new avenues for more effective and personalized therapies. One prominent trend is the advancement of immunotherapy, which harnesses the body’s immune system to recognize and eliminate cancer cells. Immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, and cancer vaccines are among the innovative immunotherapies showing promise in various cancer types. Another trend is the development of targeted therapies based on genomic profiling and molecular characteristics of tumors. Precision medicine approaches enable the selection of therapies that specifically target the genetic mutations driving cancer growth, resulting in improved treatment outcomes and reduced toxicity. Additionally, combination therapies involving multiple drugs with complementary mechanisms of action are being explored to overcome treatment resistance and enhance therapeutic efficacy. Moreover, advancements in supportive care, such as palliative care and survivorship programs, are improving the quality of life for cancer patients throughout their treatment journey. As research continues to evolve, collaborative efforts among scientists, clinicians, and pharmaceutical companies are driving the development of novel treatment modalities and biomarkers, offering hope for more effective, tailored, and accessible cancer therapies in the future.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 17Hematologic Malignancies

Hematologic malignancies are cancers that affect the blood and bone marrow. They are also known as blood cancers or hematological cancers. There are three main types of hematologic malignancies:

Leukemia: Leukemia is a cancer of the blood cells, specifically the white blood cells. It is characterized by the abnormal growth of immature white blood cells in the bone marrow, which can interfere with the production of normal blood cells.
Lymphoma: Lymphoma is a cancer of the lymphatic system, which is part of the immune system. It is characterized by the abnormal growth of lymphocytes, a type of white blood cell, in the lymph nodes, spleen, or other lymphatic tissues.
Myeloma: Myeloma is a cancer of the plasma cells, which are a type of white blood cell that produce antibodies. It is characterized by the abnormal growth of plasma cells in the bone marrow, which can interfere with the production of normal blood cells and weaken the bones.

Hematologic malignancies can cause a variety of symptoms, including fatigue, weakness, unexplained weight loss, and frequent infections. Treatment for hematologic malignancies depends on the type and stage of the cancer, as well as the patient’s age and overall health. Treatment options may include chemotherapy, radiation therapy, targeted therapy, stem cell transplantation, or a combination of these treatments.

Research into hematologic malignancies is ongoing, and new treatments are being developed and tested. Clinical trials are a critical part of this research and provide opportunities for patients to access cutting-edge treatments that may not yet be widely available.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 18Cancer Pharmacology

Cancer pharmacology is the study of drugs used in the treatment of cancer. It involves the development, testing, and use of drugs that can prevent or slow the growth of cancer cells, kill cancer cells, or prevent the spread of cancer to other parts of the body. Cancer pharmacology is a rapidly evolving field, with new drugs and treatment strategies being developed and tested regularly.

There are several types of drugs used in cancer pharmacology, including:

Chemotherapy: Chemotherapy drugs are used to kill cancer cells by disrupting their ability to grow and divide.
Targeted therapy: Targeted therapy drugs are designed to target specific molecules or pathways involved in cancer growth and progression.
Immunotherapy: Immunotherapy drugs work by stimulating the immune system to attack cancer cells.
Hormone therapy: Hormone therapy drugs are used to treat cancers that are sensitive to hormones, such as breast and prostate cancer.
Palliative care: Palliative care drugs are used to relieve symptoms associated with cancer, such as pain, nausea, and fatigue.

The development and testing of cancer drugs involve multiple phases of clinical trials, which aim to assess the safety and efficacy of the drugs in human patients. Once a drug is approved by regulatory agencies such as the U.S. Food and Drug Administration (FDA), it can be used in clinical practice to treat cancer patients.

Cancer pharmacology is a complex and rapidly evolving field, and ongoing research is aimed at identifying new drugs and treatment strategies that can improve outcomes for cancer patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 19Interventional Radiology

Interventional radiology (IR) is a specialized branch of radiology that utilizes minimally invasive procedures to diagnose and treat a wide range of medical conditions. These procedures are performed under image guidance, such as fluoroscopy, ultrasound, CT scans, or MRI, allowing for precise targeting of tissues while minimizing damage to surrounding healthy structures. Interventional radiologists are skilled in performing a diverse array of procedures, including angioplasty and stenting for vascular conditions, embolization to block blood flow to tumors or abnormal vessels, percutaneous tumor ablation using heat or cold to destroy cancer cells, and catheter-based treatments for conditions such as uterine fibroids or varicose veins. IR techniques offer several advantages over traditional surgery, including shorter recovery times, reduced risk of complications, and the ability to treat patients who may not be candidates for surgery. As technology continues to advance, the scope of interventional radiology continues to expand, with new procedures and applications being developed to address a growing range of medical conditions.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 20Molecular Imaging in Cancer

Molecular imaging in cancer involves the visualization and characterization of biological processes at the molecular and cellular levels to aid in cancer detection, diagnosis, and treatment evaluation. This advanced imaging technique utilizes targeted imaging agents, such as radiotracers, nanoparticles, or fluorescent probes, that selectively bind to specific molecular markers or biological processes associated with cancer. By detecting these molecular signatures, molecular imaging techniques like positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), and optical imaging can provide valuable information about tumor biology, heterogeneity, and treatment response.

For instance, PET imaging with radiotracers targeting glucose metabolism (FDG-PET) is widely used in oncology to detect and stage various cancers based on increased glucose uptake by cancer cells. Additionally, PET imaging with radiotracers targeting specific biomarkers, such as prostate-specific membrane antigen (PSMA) in prostate cancer or human epidermal growth factor receptor 2 (HER2) in breast cancer, can provide insights into tumor aggressiveness and guide treatment decisions.

Furthermore, molecular imaging techniques like optical imaging, which use fluorescent probes to visualize molecular targets, offer intraoperative guidance during surgery to precisely delineate tumor margins and identify tumor-involved lymph nodes. This can improve the accuracy of surgical resection and reduce the risk of tumor recurrence.

Overall, molecular imaging in cancer holds great promise for advancing personalized medicine approaches by providing non-invasive, real-time information about tumor biology and treatment response. Ongoing research in this field aims to develop novel imaging probes, improve imaging sensitivity and specificity, and integrate molecular imaging techniques into routine clinical practice to improve patient outcomes in cancer care.

Similar conferences: Tumor board conferences| Tumor meetings | World Cancer Congress | Congress of Radiology |

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 21Prostate Cancer: Early Detection and Treatment

Early detection and treatment are crucial in the management of prostate cancer, the most common cancer among men. Screening for prostate cancer typically involves a combination of digital rectal examination (DRE) and prostate-specific antigen (PSA) testing. Elevated PSA levels may indicate the presence of prostate cancer, prompting further evaluation with imaging modalities such as transrectal ultrasound (TRUS) or MRI. Early detection enables the identification of localized or locally advanced disease, when treatment options are most effective and curative. Treatment modalities for prostate cancer include active surveillance, surgery (radical prostatectomy), radiation therapy (external beam or brachytherapy), hormone therapy, and chemotherapy. The choice of treatment depends on various factors such as the patient’s age, overall health, cancer stage, and aggressiveness. For localized disease, surgery or radiation therapy are often recommended, while hormone therapy may be used for advanced or metastatic disease. Emerging therapies such as focal therapy and immunotherapy hold promise in reducing treatment-related side effects and improving long-term outcomes. Multidisciplinary collaboration among urologists, radiation oncologists, medical oncologists, and other healthcare professionals is essential in developing personalized treatment plans that optimize outcomes while minimizing morbidity. Additionally, ongoing research efforts focus on identifying biomarkers and novel therapeutic targets to further enhance early detection and treatment strategies for prostate cancer.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 22Cancer Survivorship: Challenges and Strategies

Cancer survivorship represents a crucial phase in the continuum of cancer care, encompassing the period from diagnosis, through treatment, and beyond. While advancements in cancer treatment have led to improved survival rates, cancer survivors often face a myriad of physical, psychosocial, and practical challenges that can impact their quality of life. Physical challenges may include long-term side effects of treatment, such as fatigue, pain, neuropathy, and organ dysfunction, as well as an increased risk of secondary cancers and chronic health conditions. Psychosocial challenges may involve anxiety, depression, fear of recurrence, body image issues, and difficulties adjusting to life after cancer. Practical challenges may include financial strain, employment issues, insurance coverage, and access to supportive care services.

To address these challenges, comprehensive survivorship care plans are increasingly recognized as essential components of cancer care. These plans, developed in collaboration with healthcare providers, outline a roadmap for addressing the individual needs of cancer survivors across various domains. Strategies for survivorship care may include regular surveillance for cancer recurrence and monitoring of long-term side effects, referrals to rehabilitation services, psychosocial support programs, survivorship clinics, and community resources. Lifestyle interventions focusing on nutrition, exercise, and smoking cessation can also promote overall health and well-being among cancer survivors.

Moreover, survivorship care should involve education and empowerment, enabling survivors to become active participants in their ongoing care and advocating for their needs. Peer support groups, survivorship workshops, and online communities offer opportunities for survivors to connect with others who have shared similar experiences and provide mutual support.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 23Cancer Drug Development and Clinical Trials

Cancer drug development and clinical trials are critical processes in bringing new cancer therapies to patients. The development of cancer drugs begins with extensive research and discovery, where potential drug candidates are identified based on their ability to target specific cancer cells or pathways. Once a promising compound is identified, it undergoes preclinical testing in the laboratory and in animal models to assess its safety and efficacy. If the results are positive, the drug moves into clinical trials, which are conducted in multiple phases.

Phase I trials focus on determining the safety and optimal dosage of the drug in a small group of patients. Phase II trials assess the drug’s effectiveness and further evaluate its safety in a larger group. Phase III trials involve even more patients and compare the new drug to existing standard treatments to confirm its efficacy and monitor side effects. If the drug demonstrates significant benefits, it may receive regulatory approval for use in the general population. Throughout this process, the goal is to ensure that new cancer treatments are both safe and effective, ultimately improving outcomes for patients.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 24Combination Therapies in Cancer Treatment

Combination therapies in cancer treatment involve using two or more treatment modalities simultaneously or sequentially to achieve better outcomes than single-agent therapies. Here are some common types of combination therapies used in cancer treatment:

Chemotherapy Combinations: Chemotherapy drugs work by targeting rapidly dividing cells, including cancer cells. Combining different chemotherapy agents with distinct mechanisms of action can enhance efficacy and reduce the likelihood of drug resistance. For example, the combination of platinum-based drugs like cisplatin or carboplatin with taxanes such as paclitaxel or docetaxel is often used in various cancers, including lung, ovarian, and breast cancer.
Targeted Therapy Combinations: Targeted therapies are drugs that specifically target molecular alterations driving cancer growth and progression, such as mutations in oncogenes or dysregulated signaling pathways. Combining targeted therapies that inhibit different molecular targets can enhance efficacy and overcome resistance mechanisms. For instance, in BRAF-mutant melanoma, combining BRAF inhibitors (e.g., vemurafenib) with MEK inhibitors (e.g., cobimetinib) has shown improved outcomes compared to single-agent therapy.
Immunotherapy Combinations: Immunotherapy aims to harness the body’s immune system to target and destroy cancer cells. Combining different immunotherapy agents, such as immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies) or adoptive cell therapies (e.g., CAR-T cell therapy), can enhance immune responses and improve outcomes. Additionally, combining immunotherapy with other treatment modalities like chemotherapy or targeted therapy can have synergistic effects. For example, the combination of immune checkpoint inhibitors with chemotherapy has shown improved survival in certain types of lung cancer and bladder cancer.
Radiotherapy Combinations: Radiotherapy uses high-energy radiation to kill cancer cells or inhibit their growth. It can be combined with other treatment modalities, such as surgery, chemotherapy, or targeted therapy, to enhance tumor response. For example, concurrent chemoradiotherapy is commonly used in the treatment of locally advanced cancers, such as head and neck cancer and cervical cancer, to improve local control and survival outcomes.
Sequential Therapy: In some cases, treatment modalities are administered sequentially, with one therapy followed by another. For example, neoadjuvant chemotherapy may be given before surgery to shrink tumors and facilitate surgical resection, followed by adjuvant chemotherapy to target residual disease and reduce the risk of recurrence.
Maintenance Therapy: Maintenance therapy involves continuing treatment with a lower dose or frequency after initial therapy to prolong disease control or delay disease progression. For example, in certain types of leukemia and lymphoma, patients may receive maintenance therapy with targeted agents or immunotherapy to prevent relapse.

Combination therapies are often tailored to individual patients based on factors such as cancer type, stage, molecular profile, and patient preferences. Clinical trials play a crucial role in evaluating the safety and efficacy of novel combination regimens and identifying optimal treatment strategies for different cancer types.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 25Telemedicine in Cancer Care

Telemedicine has become increasingly important in cancer care, offering various benefits to patients, caregivers, and healthcare providers. Here’s how telemedicine is being utilized in cancer care:

Remote Consultations: Telemedicine allows patients to consult with oncologists and other specialists remotely, eliminating the need for in-person visits, particularly for routine follow-ups or discussions about test results. This convenience can reduce travel time and expenses for patients, especially those living in remote or rural areas.
Access to Specialists: Telemedicine enables patients to access specialized cancer care without geographical limitations. Patients can consult with oncologists and multidisciplinary cancer care teams from renowned cancer centers, regardless of their physical location, thus ensuring access to expertise and cutting-edge treatments.
Remote Monitoring and Management: Telemedicine platforms can facilitate remote monitoring of cancer patients’ symptoms, side effects of treatment, and disease progression. This continuous monitoring allows healthcare providers to intervene promptly if any issues arise, improving patient outcomes and quality of life.
Adherence and Education: Telemedicine platforms can be used to provide educational resources and support materials to cancer patients and their families, helping them understand their diagnosis, treatment options, and self-management strategies. Additionally, telemedicine can be leveraged to promote medication adherence and lifestyle modifications through remote counseling and reminders.
Supportive Care Services: Telemedicine extends beyond medical treatment to encompass supportive care services such as psycho-oncology, nutritional counseling, and palliative care. Patients can access mental health support, nutritional guidance, and symptom management strategies remotely, enhancing their overall well-being and coping with the challenges of cancer treatment.
Clinical Trials and Research: Telemedicine facilitates patient enrollment and participation in clinical trials by removing barriers related to travel and logistics. Cancer patients can consult with research staff, undergo virtual assessments, and participate in remote monitoring of study endpoints, thereby expanding access to innovative therapies and advancing cancer research.
Coordination of Care: Telemedicine platforms facilitate communication and coordination among members of the healthcare team, including oncologists, surgeons, radiologists, pathologists, and primary care providers. This seamless exchange of information ensures continuity of care, reduces delays in treatment, and enhances patient safety.
Post-Treatment Surveillance: After completing cancer treatment, patients require regular surveillance to monitor for disease recurrence and late effects of therapy. Telemedicine allows for remote follow-up visits and surveillance testing, reducing the burden on patients and healthcare resources while ensuring timely detection of any complications.
Emergency Consultations: In cases where cancer patients experience urgent medical issues or treatment-related complications, telemedicine can provide timely access to oncology expertise, enabling rapid assessment and management of acute concerns without the need for emergency department visits or hospitalizations.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 26Radiation Therapy: Techniques and Outcomes

Radiation therapy is a cornerstone of cancer treatment, utilizing high-energy radiation to target and destroy cancer cells while minimizing damage to surrounding healthy tissues. Various techniques and modalities are employed to deliver radiation therapy effectively, tailored to the specific characteristics of each patient’s cancer.

External beam radiation therapy (EBRT) is the most common form of radiation therapy, where a machine delivers radiation from outside the body directly to the tumor and nearby tissues. Advanced EBRT techniques such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) enable precise targeting of tumors while sparing adjacent organs, resulting in better treatment outcomes and reduced side effects.

Brachytherapy is another technique used in radiation therapy, involving the placement of radioactive sources directly into or near the tumor. This approach allows for the delivery of high doses of radiation to the tumor while minimizing exposure to surrounding healthy tissues, making it particularly effective for certain cancers such as prostate, cervical, and breast cancer.

The outcomes of radiation therapy vary depending on factors such as cancer type, stage, location, and patient factors. For many patients, radiation therapy can effectively control or eliminate cancer, leading to improved survival rates and quality of life. In some cases, radiation therapy may be used as the primary treatment modality, while in others, it may be combined with surgery, chemotherapy, or immunotherapy to enhance treatment efficacy.

While radiation therapy can cause side effects such as fatigue, skin irritation, and changes in bowel or bladder function, modern techniques aim to minimize these side effects through careful treatment planning and delivery. Overall, radiation therapy continues to play a crucial role in cancer treatment, offering effective and personalized therapeutic options for patients across a wide range of cancer types.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 27Lung Cancer

Lung cancer is a type of cancer that starts in the lungs, most commonly in the cells that line the air passages. It is the leading cause of cancer-related deaths worldwide, with smoking being the primary risk factor. However, non-smokers can also develop lung cancer due to factors such as exposure to secondhand smoke, environmental pollutants, or genetic predisposition.

There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most common type, accounting for about 85% of all lung cancers, and includes subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. SCLC, although less common, tends to grow and spread more aggressively.

Symptoms of lung cancer may include persistent cough, coughing up blood, chest pain, shortness of breath, hoarseness, fatigue, unexplained weight loss, and recurrent respiratory infections. However, lung cancer may not cause noticeable symptoms in its early stages, which is why screening for high-risk individuals, such as current or former smokers, is essential for early detection.

Treatment options for lung cancer depend on several factors, including the type and stage of cancer, as well as the patient’s overall health and preferences. Treatment modalities may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches. Advances in precision medicine have led to the development of targeted therapies and immunotherapies that specifically target genetic mutations or immune checkpoints, leading to improved outcomes and quality of life for some patients.

Prevention strategies for lung cancer primarily involve avoiding tobacco smoke, including quitting smoking and avoiding exposure to secondhand smoke. Additionally, reducing exposure to environmental pollutants such as radon, asbestos, and air pollution can lower the risk of developing lung cancer.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 28Radiology in Pediatric Oncology

Radiology plays a crucial role in pediatric oncology by providing essential diagnostic and monitoring tools throughout the treatment process. Imaging modalities such as X-rays, ultrasound, CT scans, MRI scans, and nuclear medicine scans are used to detect, diagnose, stage, and monitor pediatric cancers.

In the diagnostic phase, radiological imaging helps identify suspicious lesions, determine the extent of disease involvement, and guide the selection of appropriate biopsy sites. Imaging findings aid in distinguishing between benign and malignant tumors, as well as in characterizing tumor characteristics such as size, location, and vascular involvement.

During treatment, radiological imaging is utilized to assess treatment response, monitor disease progression or regression, and detect any treatment-related complications. For example, MRI scans are commonly used to evaluate brain tumors and assess response to chemotherapy or radiation therapy. CT scans and PET scans provide valuable information about tumor size, metabolic activity, and response to treatment in various pediatric cancers.

Furthermore, radiological imaging plays a vital role in surveillance imaging following completion of treatment, helping to detect any signs of disease recurrence or metastasis at an early stage. Regular follow-up imaging is essential to monitor for late effects of treatment, such as radiation-induced changes or secondary malignancies.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 29Tumor Biomarkers

Tumor biomarkers are molecular or genetic features that can be detected in tumor tissues, blood, or other bodily fluids and provide valuable information about the presence, characteristics, behavior, or prognosis of cancer. These biomarkers play a crucial role in cancer diagnosis, prognosis, treatment selection, and monitoring of treatment response.

In diagnosis, tumor biomarkers help distinguish between different types of cancer and subtypes within a particular cancer type, aiding in the accurate classification of tumors and guiding appropriate treatment strategies. For example, specific biomarkers such as HER2/neu expression in breast cancer or BRAF mutation status in melanoma can inform treatment decisions and predict response to targeted therapies.

In prognosis, tumor biomarkers provide information about the likelihood of disease progression, recurrence, or survival outcomes. High levels of certain biomarkers may indicate a more aggressive tumor phenotype or poor prognosis, prompting closer monitoring and more aggressive treatment approaches. Conversely, favorable biomarker profiles may suggest a better prognosis and guide decisions regarding the intensity and duration of treatment.

In treatment selection, tumor biomarkers help identify patients who are most likely to benefit from specific therapies while minimizing unnecessary treatment-related toxicities. Biomarker-driven therapies, such as hormone receptor testing in breast cancer or EGFR mutation testing in lung cancer, allow for personalized treatment approaches tailored to the unique molecular characteristics of each patient’s tumor.

In monitoring of treatment response, tumor biomarkers serve as indicators of treatment effectiveness and disease status over time. Changes in biomarker levels or expression patterns during or after treatment can provide insights into treatment response, disease recurrence, or emergence of treatment resistance, guiding adjustments to therapy and ongoing management strategies.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Session 30Oncologic Emergencies

Oncologic emergencies are critical medical conditions that arise as a result of cancer or its treatment, requiring prompt recognition and intervention to prevent serious complications or death. These emergencies can occur due to direct tumor-related complications, such as tumor obstruction or infiltration of vital structures, or as a consequence of cancer treatment, such as chemotherapy-induced side effects or infections related to immunosuppression.

Common oncologic emergencies include tumor lysis syndrome, where rapid tumor cell breakdown releases toxins into the bloodstream, leading to electrolyte imbalances and kidney failure. Another example is spinal cord compression, which occurs when a tumor compresses the spinal cord, resulting in neurological deficits. Additionally, febrile neutropenia, caused by chemotherapy-induced suppression of the bone marrow and subsequent infection, is a life-threatening complication that requires immediate antibiotic therapy.

Other oncologic emergencies include hypercalcemia of malignancy, caused by tumor secretion of parathyroid hormone-related protein leading to elevated blood calcium levels, and superior vena cava syndrome, resulting from obstruction of the superior vena cava by a tumor mass, leading to swelling of the face, neck, and upper body.

Prompt recognition and management of oncologic emergencies are essential to prevent further complications and improve patient outcomes. Treatment may include supportive measures such as fluid resuscitation, electrolyte correction, pain management, and antibiotics, as well as interventions such as radiation therapy, chemotherapy dose adjustment, or surgical decompression, depending on the specific emergency.

Effective communication and collaboration among healthcare providers, including oncologists, emergency physicians, radiologists, and nurses, are crucial in the timely identification and management of oncologic emergencies. Education and training of healthcare professionals and patients about the signs and symptoms of these emergencies can also facilitate early recognition and intervention, ultimately improving patient outcomes and quality of care.

Important links:
Download the brochure of the Cancer & Radiology
Submit the Abstract on above Cancer session
Register for the Cancer & Radiology

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram